HOLX קצב צמיחת רווח למניה בשנה הנוכחית hologic.com

סמל תאגידי ולוגו של Hologic, Inc. (HOLX)

Hologic, Inc. (HOLX) demonstrates high recession resistance due to its focus on mammography. Stability is ensured by the critical importance of cancer diagnostics, which guarantees resilience against macro shocks. Analyzing the annual evolution of earnings per share on GURU.Markets, we note that 3.90 serves as the base value of the parameter. However, market saturation and the struggle for government budgets force the company to constantly invest in innovative startups.

צמיחת רווח למניה בשנה הנוכחית Hologic Corp (HOLX): לתקופה 04.07.2022 - 18.04.2026

פילוחים אנליטיים ודוחות נתונים של חברת Hologic, Inc. (HOLX)

- שווי מניות ותחזית קונצנזוס למחירים:
הערכת שווי פונדמנטלית:HOLX Hologic Inc
מוצרים מיוצרים של Hologic

The year-over-year percentage change in earnings per share allows for the mitigation of the quarterly reporting time lag, ensuring continuous monitoring of the asset's financial stability. By analyzing the annual EPS trend, an investor assesses the pace of net income generation, which for Hologic, Inc. (HOLX) confirms the effectiveness of monetizing the installed base of mammography systems through the sale of high-margin consumables.